scleroderma
-
Exton’s Fibrocell Science Seeks Approval for Testing of Treatment for Rare Skin Disorder
Fibrocell Science in Exton is seeking approval from the FDA to start human testing of its experimental treatment for scleroderma, a rare autoimmune skin disorder,…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
